Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma
Clinical trial NCT03682276 · COMPLETED
Trial details
- NCT number
- NCT03682276
- Sponsor
- Imperial College London
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2026-03-12
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.